Related Experiment Videos
Letter: Brain scanning in metastatic disease
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Nuclear scintigraphic assessment of intestinal dysfunction after combined treatment with 9-amino-20(S)-camptothecin (9-AC) and irradiation.
International journal of radiation oncology, biology, physics·2000
Use of a reusable shielded marker to enhance the accuracy, safety, and efficacy of nuclear medicine procedures.
Clinical nuclear medicine·2000
Nuclear scintigraphic assessment of radiation-induced intestinal dysfunction.
Radiation research·2000
Validity of methods of body composition assessment in young and older men and women.
Journal of applied physiology (Bethesda, Md. : 1985)·1999
Patient Survival and Its Relation to Tumor Absorbed Dose in [177Lu]Lu-DOTATATE Therapy of Neuroendocrine Tumors.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Normal Tissue Dosimetry of Intraperitoneal 224Ra Microparticle Therapy: Data from First-in-Human Studies in Patients with Peritoneal Metastases.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Real-World Outcomes of [177Lu]Lu-PSMA-617 in the French Early-Access Program for Patients with Metastatic Castration-Resistant Prostate Cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Concordance Between [18F]Flortaucipir PET Visual Reads and CenTauR-Based Quantification.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Neuroinflammatory PET in Epilepsy: Prospects for Epileptogenic Zone Localization and Presurgical Planning.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Tumor and Organ Dose Estimates from 177Lu-PSMA-617 Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: Results from the RESIST-PC Phase 2 Trial.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Survivin mRNA lipid nanoparticles and CTLA-4 inhibitor co-delivery activates anti-tumor cytotoxic T-lymphocytes for oral cancer immunotherapy.
Medical oncology (Northwood, London, England)·2026
Species-specific functions of CSRP3 in satellite cell-driven muscle regeneration and relevance to porcine stem cell therapy.
Cell regeneration (London, England)·2026
Are SGLT2 inhibitors really associated with increased urinary tract infection risk? A trial-level meta-analysis across type 2 diabetes, heart failure, and chronic kidney disease.
Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences·2026
Mechanistic basis of G595R-mediated resistance to entrectinib in TRK kinase: a structural-energetic perspective.
Journal of molecular modeling·2026
Beyond nuclear export: chromatin-bound XPO1/CRM1 as a transcriptional scaffold.
International journal of hematology·2026